Ian Lewis
Cardiff University
60 Papers
303 Citations
Ian Lewis is an academic researcher from Cardiff University. The author has contributed to research in topics: Video game & Medicine. The author has an hindex of 15, co-authored 54 publications. Previous affiliations of Ian Lewis include University of Tasmania.
Chat about Author
Papers
Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study.
Alan W. Craft,Simon Cotterill,A. J. Malcolm,D. Spooner,R Grimer,Robert L. Souhami,J. Imeson,Ian Lewis +7 more
TL;DR: The 5-year survival rate of 62% is improved compared with the 44% survival rate achieved in ET-1, probably caused by the use of higher doses of ifosfamide compared with relatively low doses of cyclophosphamide inET-1.
221
Results of the EICESS-92 Study: Two Randomized Trials of Ewing's Sarcoma Treatment—Cyclophosphamide Compared With Ifosfamide in Standard-Risk Patients and Assessment of Benefit of Etoposide Added to Standard Treatment in High-Risk Patients
Michael Paulussen,Alan W. Craft,Ian Lewis,Allan Hackshaw,Carolyn Douglas,Jürgen Dunst,Andreas Schuck,Winfried Winkelmann,Gabriele Köhler,Christopher Poremba,Andreas Zoubek,Ruth Ladenstein,Henk van den Berg,Andrea Hunold,A Cassoni,D. Spooner,Robert J. Grimer,Jeremy Whelan,Anne McTiernan,Herbert Jürgens +19 more
TL;DR: Cyclophosphamide seemed to have a similar effect on EFS and OS as ifosfamide in SR patients but was associated with increased toxicity and in HR patients, the addition of etoposide seemed to be beneficial.
202
Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials
Jeremy Whelan,Rachel C. Jinks,Anne McTiernan,Matthew R. Sydes,James M. Hook,L. Trani,B. M. Uscinska,Vivien H.C. Bramwell,Ian Lewis,M. Nooij,M. van Glabbeke,Robert J. Grimer,Pancras C.W. Hogendoorn,Antonie H. M. Taminiau,Hans Gelderblom +14 more
TL;DR: Good histological response to preoperative chemotherapy, distal tumour location and female gender were associated with improved survival, and localised osteosarcoma will be cured in 50% of patients with cisplatin and doxorubicin.
200
Singing modulates mood, stress, cortisol, cytokine and neuropeptide activity in cancer patients and carers.
TL;DR: Preliminary evidence is provided that singing improves mood state and modulates components of the immune system in populations affected by cancer.
Current state of quality of life and patient-reported outcomes research
Andrew Bottomley,Jaap C. Reijneveld,Michael Koller,Henning Flechtner,Krzysztof A. Tomaszewski,Eva Greimel,Patricia A. Ganz,Jolie Ringash,Daniel O’Connor,Paul G. Kluetz,Giovanni Tafuri,Mogens Grønvold,Claire F. Snyder,Carolyn C. Gotay,Dame Lesley Fallowfield,Kathi Apostolidis,Roger Wilson,Richard Stephens,Holger J. Schünemann,Melanie Calvert,Bernhard Holzner,Jammbe Z. Musoro,Sally Wheelwright,Francesca Martinelli,Amylou C. Dueck,Madeline Pe,Corneel Coens,Galina Velikova,Dagmara Kuliś,Martin J.B. Taphoorn,Anne-Sophie Darlington,Ian Lewis,Lonneke V. van de Poll-Franse +32 more
TL;DR: The 5th EORTC Quality of Life in Cancer Clinical Trials Conference presented the current state of quality of life and other patient-reported outcomes (PROs) research from the perspectives of researchers, regulators, industry representatives, patients and patient advocates and health care professionals.
137